Statistics for Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
Total visits
views | |
---|---|
Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration | 222 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
1.pdf | 167 |
java.util.UUID:91d1316c-7318-4246-b440-27983f91f878 | 39 |
java.util.UUID:59ad18d2-abd9-43ed-a070-ea5af05aa98d | 17 |
java.util.UUID:3ffc5fa8-e3de-43cf-8155-753e96766b7e | 7 |
Top country views
views | |
---|---|
United States | 175 |
Germany | 11 |
Russia | 6 |
Ukraine | 6 |
China | 3 |
United Kingdom | 3 |
Canada | 2 |
Malaysia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 54 |
Fairfield | 25 |
Houston | 16 |
Ann Arbor | 12 |
Cambridge | 9 |
Kiez | 8 |
Jacksonville | 7 |
Kiev | 6 |
Saint Petersburg | 4 |
San Francisco | 3 |
Baltimore | 2 |
Beijing | 2 |
London | 2 |
Toronto | 2 |
Brooklyn | 1 |
Chicago | 1 |
Frankfurt Am Main | 1 |
Gunzenhausen | 1 |
Kansas City | 1 |
Lake Mary | 1 |
Moscow | 1 |
Mountain View | 1 |
Netze | 1 |
New York | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |
Shenzhen | 1 |
Stockholm | 1 |
Washington | 1 |